Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: Effects of maternal characteristics and medical history

Ultrasound in Obstetrics and Gynecology

Volumn 45, Issue 5, 2015, Pages 584-590

  Tsiakkas, A ^a   Duvdevani, N ^a   Wright, A ^b   Wright, D ^b   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

first trimester screening; pre eclampsia; pyramid of pregnancy care; second trimester screening; sFlt 1; soluble fms like tyrosine kinase 1; third trimester screening; trisomy 21

Indexed keywords

BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ANAMNESIS; BLOOD; BODY MASS; FEMALE; GESTATIONAL AGE; GREAT BRITAIN; HUMAN; PREDICTIVE VALUE; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; BIOMARKERS; BODY MASS INDEX; FEMALE; GESTATIONAL AGE; GREAT BRITAIN; HUMANS; MEDICAL HISTORY TAKING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; PREGNANCY TRIMESTERS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84928468686     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14817     Document Type: Article

References (14)

1. Maynard SE, Min JY, Merchan J, Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA,. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
2. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA,. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
3. Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, Dong Z, Tarca A, Gaurav B, Hassan SS,. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 2011; 24: 1187-1207.
4. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H,. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in pre-eclamptic patients. Am J Obstet Gynecol 2012; 206: 58.e1-8.
5. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA,. Angiogenic factors and the risk of adverse outcomes in women with suspected pre-eclampsia. Circulation 2012; 125: 911-919.
6. Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH,. Competing risks model in screening for pre-eclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation. Fetal Diagn Ther 2014; 35: 240-248.
7. Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH,. A competing risks model in early screening for pre-eclampsia. Fetal Diagn Ther 2012; 32: 171-178.
8. Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH,. Competing risks model in early screening for pre-eclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013; 33: 8-15.
9. Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH,. Competing risks model in screening for pre-eclampsia by maternal characteristics and medical history. Am J Obstet Gynecol 2015 (in press).
10. Robinson HP, Fleming JE,. A critical evaluation of sonar crown-rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
11. Snijders RJ, Nicolaides KH,. Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol 1994; 4: 34-48.
12. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM,. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: 19-24.
13. Poon LCY, Volpe N, Muto B, Syngelaki A, Nicolaides KH,. Birth weight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 2012; 32: 156-165.
14. R Development Core Team R. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2011. ISBN 3-900051-07-0. http://www.R-project.org/.